TY - JOUR
T1 - COVID 19 and ethnicity
T2 - spot light on the global rheumatology issues in developing and developed countries
AU - Moorthy, Arumugam
AU - Dubey, Shirish
AU - Samanta, Ash
AU - Adebajo, Ade
AU - Aggarwal, Amita
AU - Jain, Avinash
AU - Jain, Nibha
AU - Lim, S. Sam
AU - Kerr, Gail S.
AU - Kumar, Kanta
PY - 2020/7
Y1 - 2020/7
N2 - A key issue in the response to the coronavirus disease 2019 (COVID‐19) pandemic is the internationally recognised observation that COVID‐19 disproportionally affects the Black and Minority Ethnic Population (BAME) (1). We focus predominantly on the countries of the UK, USA, and India COVID‐19 rheumatology challenges and examples. This unprecedented public health crisis started in China in Dec 2019, following an infection caused by a novel coronavirus strain, named as SARS‐CoV2 (2). The World Health Organisation in March 2020 declared this public health emergency as a pandemic (2). COVID‐19 pandemic has moved from country to country peaking at different times despite implementation of strict preventive measures, including complete lock down periods with varied success. Case fatality and mortality rates have been highly variable across nations as well as different ethnic groups (3).
AB - A key issue in the response to the coronavirus disease 2019 (COVID‐19) pandemic is the internationally recognised observation that COVID‐19 disproportionally affects the Black and Minority Ethnic Population (BAME) (1). We focus predominantly on the countries of the UK, USA, and India COVID‐19 rheumatology challenges and examples. This unprecedented public health crisis started in China in Dec 2019, following an infection caused by a novel coronavirus strain, named as SARS‐CoV2 (2). The World Health Organisation in March 2020 declared this public health emergency as a pandemic (2). COVID‐19 pandemic has moved from country to country peaking at different times despite implementation of strict preventive measures, including complete lock down periods with varied success. Case fatality and mortality rates have been highly variable across nations as well as different ethnic groups (3).
UR - http://www.scopus.com/inward/record.url?scp=85087214036&partnerID=8YFLogxK
U2 - 10.1111/1756-185X.13883
DO - 10.1111/1756-185X.13883
M3 - Article
C2 - 32473047
SN - 1756-1841
VL - 23
SP - 849
EP - 852
JO - International Journal of Rheumatic Diseases
JF - International Journal of Rheumatic Diseases
IS - 7
ER -
